Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry

Salah-Eddin Al-Batran, Ralf-Dieter Hofheinz, Alexander Reichart, Claudia Pauligk, Caroline Schoenherr, Rudolf Schlag, Gabriele Siegler, Steffen Doerfel, Michael Koenigsmann, Mark-Oliver Zahn, Joerg Schubert, Ali Aldaoud, Heinz-Gert Hoeffkes, Holger Schulz, Lars Hahn, Jens Uhlig, Wolfgang Blau, Martina Stauch, Joerg Weniger, Martin WolfLutz Jacobasch, Stephan Bildat, Juergen Wehmeyer, Nils Homann, Joerg Trojan, Oliver Waidmann, Thomas Fietz, Hans-Peter Feustel, Matthias Groschek, Jan Wierecky, Karin Waibel, Stefan Mahlmann, Uwe Schwindel, Uwe Peters, Gunter Schuch, Daniel Pink, Henning Eschenburg, Marcus-A Woerns, Hans-Detlev Harich, Ludwig Fischer von Weikersthal, Klaus-Ulrich Daessler, Dirk M. Behringer, Helmut Messmann, Albrecht Kretzschmar, Eike Gallmeier, Helmut Forstbauer, Volker Kunzmann, Jens Papke, Petra Buechner-Steudel, Ursula Vehling-Kaiser, Christoph Springfeld, Arndt Vogel, Thomas J. Ettrich, Marina Schaaf, Gerrit zur Hausen, Thorsten Oliver Goetze

Research output: Contribution to journalOriginal Articlepeer-review

12 Citations (Web of Science)
Original languageUndefined/Unknown
JournalINTERNATIONAL JOURNAL OF CANCER
DOIs
Publication statusPublished - 2021

Cite this